Home LiteratureArticle Details
PMID: 18175065 Published · ppublish English Journal Article Review

Chronic kidney disease perspectives in Japan and the importance of urinalysis screening.

Clinical and experimental nephrology ·Vol. 12 ·No. 1 ·2008-02-00 ·Pages 1-8

Yamagata K, Iseki K, Nitta K, Imai H, Iino Y, Matsuo S, Makino H, Hishida A

Abstract

There are racial differences in primary renal diseases for end-stage renal disease (ESRD) and the incidence and prevalence of cardiovascular disease (CVD). To reduce the number of patients with both ESRD and CVD, an effective screening method for CKD should be established. In Japan, screening with the urine dip-stick test for proteinuria has been used since 1972 targeting every child and worker and since 1983 for every resident over 40 years old. There are several reasons for continuing this screening program. First, the positive rate of proteinuria is high in the Japanese general population, especially subjects with neither hypertension nor diabetes. Most of these subjects have no symptoms, and the only sign of renal disease is asymptomatic urinary abnormalities. Second, the prevalence and incidence of glomerulonephritis, especially IgA nephropathy, are high in the Japanese and Asian races, and urinalysis is the only method for early detection of chronic glomerulonephritis. Third, 10-year survival of the ESRD patients due to glomerulonephritis was approximately twice that of ESRD patients due to diabetes and nephrosclerosis. Consequently, reducing the incidence of ESRD due to glomerulonephritis is one of the best ways to reduce the prevalence of ESRD. Furthermore, higher incidence of ESRD in Asian races than in Caucasians was reported. Proteinuria is known to be the best predictor for reducing renal function, and the urine dip-stick test for proteinuria is less expensive and is cost-effective. For an effective screening strategy to reduce the ESRD population in Japanese and Asians, universal screening with the urine dip-stick test for proteinuria could be one solution.

MeSH Terms
Adult Aged Aged, 80 and over Asians/statistics & numerical data Glomerulonephritis/diagnosis,prevention & control Glomerulonephritis, IGA/epidemiology Humans Japan/epidemiology Kidney Failure, Chronic/diagnosis,epidemiology,ethnology Mass Screening Middle Aged Proteinuria/diagnosis Renal Replacement Therapy/statistics & numerical data Urinalysis
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Yamagata Kunihiro
Department of Nephrology, Institute of Clinical Medicine, Graduate School of Comprehensive Human Science, University of Tsukuba, Tsukuba, Japan. k-yamaga@md.tsukuba.ac.jp
Iseki Kunitoshi
Nitta Kousaku
Imai Hirokazu
Iino Yasuhiko
Matsuo Seiichi
Makino Hirofumi
Hishida Akira
References (73)
73 references, click to expand
  1. Racial differences in trends of end-stage renal disease, by primary diagnosis--United States, 1994-2004.
    MMWR Morb Mortal Wkly Rep. 2007 Mar 23;56(11):253-6 PMID: 17380108
  2. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease.
    Am J Kidney Dis. 1998 Nov;32(5):853-906 PMID: 9820460
  3. The burden of kidney disease: improving global outcomes.
    Kidney Int. 2004 Oct;66(4):1310-4 PMID: 15458424
  4. Proteinuria screening for children.
    Kidney Int Suppl. 2005 Apr;(94):S23-7 PMID: 15752235
  5. Epidemiology of primary glomerular diseases in a French region. Variations according to period and age.
    Kidney Int. 1994 Oct;46(4):1192-8 PMID: 7861716
  6. Prognosis of asymptomatic hematuria and/or proteinuria in men. High prevalence of IgA nephropathy among proteinuric patients found in mass screening.
    Nephron. 2002 May;91(1):34-42 PMID: 12021517
  7. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study.
    Kidney Int. 2006 Aug;70(4):751-6 PMID: 16807548
  8. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications.
    Kidney Int Suppl. 2005 Sep;(98):S7-S10 PMID: 16108976
  9. Albuminuria as early test for vascular disease.
    Lancet. 2005 Feb 12-18;365(9459):556-7 PMID: 15708086
  10. Proteinuria and the risk of developing end-stage renal disease.
    Kidney Int. 2003 Apr;63(4):1468-74 PMID: 12631363
  11. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk.
    J Am Soc Nephrol. 2006 Aug;17(8):2275-84 PMID: 16790511
  12. Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND).
    Diabetes. 2007 Jun;56(6):1577-85 PMID: 17363742
  13. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy.
    Am J Kidney Dis. 2001 Oct;38(4):736-43 PMID: 11576876
  14. Predicting progression in IgA nephropathy.
    Am J Kidney Dis. 2001 Oct;38(4):728-35 PMID: 11576875
  15. Age distribution and yearly changes in the incidence of ESRD in Japan.
    Am J Kidney Dis. 2004 Mar;43(3):433-43 PMID: 14981601
  16. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010.
    J Am Soc Nephrol. 2001 Dec;12(12):2753-8 PMID: 11729245
  17. Exploring the differences in epidemiology of treated ESRD between Germany and England and Wales.
    Am J Kidney Dis. 2006 Mar;47(3):445-54 PMID: 16490623
  18. Dual renin-angiotensin system blockade at optimal doses for proteinuria.
    Kidney Int. 2002 Sep;62(3):1020-5 PMID: 12164886
  19. Risk of developing end-stage renal disease in a cohort of mass screening.
    Kidney Int. 1996 Mar;49(3):800-5 PMID: 8648923
  20. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey.
    BMJ. 2006 Nov 18;333(7577):1047 PMID: 17062598
  21. Corticosteroids in IgA nephropathy: a randomised controlled trial.
    Lancet. 1999 Mar 13;353(9156):883-7 PMID: 10093981
  22. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study.
    Kidney Int. 2007 Jan;71(2):159-66 PMID: 17136030
  23. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.
    Ann Intern Med. 2003 Aug 19;139(4):244-52 PMID: 12965979
  24. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III.
    Kidney Int. 2002 Jun;61(6):2165-75 PMID: 12028457
  25. Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP).
    Am J Kidney Dis. 2003 Jul;42(1):22-35 PMID: 12830453
  26. Trends in incidence of end-stage renal failure in Australia, 1972-1991.
    Nephrol Dial Transplant. 1994;9(10):1377-82 PMID: 7816248
  27. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.
    Am J Kidney Dis. 2003 Jan;41(1):1-12 PMID: 12500213
  28. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes.
    J Clin Invest. 2006 Feb;116(2):288-96 PMID: 16453013
  29. High incidence of end-stage renal disease in Indo-Asians in the UK.
    QJM. 1995 Mar;88(3):191-5 PMID: 7767669
  30. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
    J Am Soc Nephrol. 2007 May;18(5):1540-6 PMID: 17409317
  31. Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy.
    Am J Kidney Dis. 2000 Feb;35(2):194-201 PMID: 10676716
  32. Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study.
    Int J Epidemiol. 2004 Feb;33(1):189-98 PMID: 15075168
  33. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.
    J Am Soc Nephrol. 2004 May;15(5):1307-15 PMID: 15100371
  34. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.
    Kidney Int. 2004 Jun;65(6):2309-20 PMID: 15149345
  35. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
    N Engl J Med. 2004 Sep 23;351(13):1285-95 PMID: 15385655
  36. Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA?
    Kidney Int. 2006 Apr;69(8):1455-8 PMID: 16531983
  37. Maintenance dialysis population dynamics: current trends and long-term implications.
    J Am Soc Nephrol. 2002 Jan;13 Suppl 1:S37-40 PMID: 11792760
  38. Regional variability in the incidence of end-stage renal disease: an epidemiological approach.
    Nephrol Dial Transplant. 2003 Aug;18(8):1562-7 PMID: 12897095
  39. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.
    Circulation. 2002 Oct 1;106(14):1777-82 PMID: 12356629
  40. Differences in use of peritoneal dialysis and survival among East Asian, Indo Asian, and white ESRD patients in Canada.
    Am J Kidney Dis. 2006 Dec;48(6):964-71 PMID: 17162151
  41. South-Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch-European diabetic patients.
    Diabetes Care. 2006 Jun;29(6):1383-5 PMID: 16732026
  42. Use of albumin creatinine ratio and urine albumin concentration as a screening test for albuminuria in an Indo-Asian population.
    Nephrol Dial Transplant. 2007 Aug;22(8):2194-200 PMID: 17405790
  43. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999.
    J Am Soc Nephrol. 2005 Feb;16(2):489-95 PMID: 15590763
  44. Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.
    Kidney Int. 2001 Sep;60(3):1131-40 PMID: 11532109
  45. Kidney Early Evaluation Program (KEEP). Findings from a community screening program.
    Diabetes Educ. 2004 Mar-Apr;30(2):196-8, 200-2, 206 PMID: 15095511
  46. Factors affecting renal function in 119 985 adults over three years.
    QJM. 2001 Oct;94(10):541-50 PMID: 11588213
  47. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study.
    Kidney Int. 2005 Jul;68(1):228-36 PMID: 15954912
  48. Heterogeneity of prognosis in adult IgA nephropathy, especially with mild proteinuria or mild histological features.
    Intern Med. 2001 Aug;40(8):697-702 PMID: 11518105
  49. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.
    N Engl J Med. 2004 Sep 23;351(13):1296-305 PMID: 15385656
  50. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population.
    Kidney Int. 2006 Apr;69(7):1264-71 PMID: 16501489
  51. From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria.
    Kidney Int. 2004 Dec;66(6):2109-18 PMID: 15569300
  52. The commonest glomerulonephritis in the world: IgA nephropathy.
    Q J Med. 1987 Sep;64(245):709-27 PMID: 3329736
  53. End-stage renal disease in Indo-Asians in the North-West of England.
    QJM. 2003 Jul;96(7):499-504 PMID: 12881592
  54. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.
    N Engl J Med. 2001 Sep 20;345(12):861-9 PMID: 11565518
  55. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).
    Kidney Int. 2005 Jun;67(6):2089-100 PMID: 15882252
  56. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening.
    J Am Soc Nephrol. 2006 Sep;17(9):2582-90 PMID: 16899519
  57. Health-related quality of life among dialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study.
    Kidney Int. 2003 Nov;64(5):1903-10 PMID: 14531826
  58. Proteinuria: its clinical importance and role in progressive renal disease.
    Am J Kidney Dis. 2000 Apr;35(4 Suppl 1):S97-105 PMID: 10766008
  59. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.
    Circulation. 2004 Aug 24;110(8):921-7 PMID: 15302780
  60. Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom.
    Diabet Med. 1992 Aug-Sep;9(7):641-5 PMID: 1511571
  61. Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men.
    Am J Kidney Dis. 2002 Jul;40(1):1-8 PMID: 12087554
  62. Risk factors for proteinuria in a large, multiracial, southeast Asian population.
    J Am Soc Nephrol. 2002 Jul;13(7):1907-17 PMID: 12089388
  63. Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part i: morbidity and mortality monitoring.
    Circulation. 2001 Jan 23;103(3):462-8 PMID: 11157701
  64. Epidemiological features of CKD in Taiwan.
    Am J Kidney Dis. 2007 Jan;49(1):46-55 PMID: 17185145
  65. The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy.
    Kidney Int. 2003 May;63(5):1861-7 PMID: 12675864
  66. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study.
    Am J Kidney Dis. 2000 Jan;35(1):157-65 PMID: 10620560
  67. Screening for proteinuria in US adults: a cost-effectiveness analysis.
    JAMA. 2003 Dec 17;290(23):3101-14 PMID: 14679273
  68. Epidemiology of idiopathic glomerular disease: a prospective study.
    Kidney Int. 1987 Jul;32(1):112-6 PMID: 3626293
  69. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases.
    Am J Kidney Dis. 1997 Apr;29(4):526-32 PMID: 9100040
  70. Dipstick urinalysis screening of asymptomatic adults for urinary tract disorders. I. Hematuria and proteinuria.
    JAMA. 1989 Sep 1;262(9):1214-9 PMID: 2668582
  71. Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).
    Kidney Int. 2006 Dec;70(12):2058-65 PMID: 17003817
  72. Proteinuria and progression in human glomerular diseases.
    Am J Nephrol. 1990;10 Suppl 1:81-7 PMID: 2256480
  73. A long-term follow-up study of asymptomatic hematuria and/or proteinuria in adults.
    Clin Nephrol. 1996 May;45(5):281-8 PMID: 8738658
Article Info
Journal
Clinical and experimental nephrology
Abbr.
Clin Exp Nephrol
ISSN
1342-1751
Published
2008-02-00
Epub
2008-00-05
Pages
1-8
Language
English
Region
Japan
NLM ID
9709923
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com